Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review
- PMID: 31037426
- PMCID: PMC6541017
- DOI: 10.1007/s00223-019-00550-z
Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review
Abstract
Fibrous dysplasia is an uncommon mosaic disorder in which bone is replaced by structurally unsound fibro-osseous tissue. It is caused by the sporadic post-zygotic activating mutations in GNAS, resulting in dysregulated GαS-protein signaling in affected tissues. This manifests on a broad clinical spectrum ranging from insignificant solitary lesions to severe disease with deformities, fractures, functional impairment, and pain. Fibrous dysplasia may present in isolation or in association with hyperfunctioning endocrinopathies and café-au-lait macules, known as McCune-Albright Syndrome. This review summarizes the current understanding of pathophysiology in fibrous dysplasia, describes key pre-clinical and clinical investigations, and details the current approach to diagnosis and management.
Keywords: Bone disorders; Bone metabolism; FGF23-mediated hypophosphatemia; McCune–Albright syndrome.
Figures
References
-
- Yang L, et al., Prevalence of Different Forms and Involved Bones of Craniofacial Fibrous Dysplasia. J Craniofac Surg, 2017. 28(1): p. 21–25. - PubMed
-
- Weinstein LS, et al., Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med, 1991. 325(24): p. 1688–95. - PubMed
-
- Michienzi S, et al., GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs alpha. Hum Mol Genet, 2007. 16(16): p. 1921–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
